Delić

Ketamine Wellness Centers (KWC) Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

Retrieved on: 
Thursday, September 29, 2022

Under Medicare, KWC is accepting a limited number of patients for ketamine infusion therapy at the eight clinics and the FDA-approved SPRAVATO esketamine treatment at the Houston, Jacksonville and Seattle locations if they meet the criteria for insurance coverage.

Key Points: 
  • Under Medicare, KWC is accepting a limited number of patients for ketamine infusion therapy at the eight clinics and the FDA-approved SPRAVATO esketamine treatment at the Houston, Jacksonville and Seattle locations if they meet the criteria for insurance coverage.
  • Patients navigating the complexities of healthcare coverage will have access to the company's experienced team of insurance experts who will assist as Medicare coverage is introduced.
  • "Many insurance organizations around the country continue to classify ketamine as 'experimental' allowing them to resist covering patients of many other ketamine clinics who, unlike KWC, do not have specialized in-house insurance teams.
  • Ketamine Wellness Centers (KWC) is the largest ketamine therapy provider in the United States with 13 clinic locations serving communities across nine states.

DELIC HOLDINGS CORP ANNOUNCES FILING OF ANNUAL DOCUMENTS

Retrieved on: 
Tuesday, May 31, 2022

While the MCTO remains in effect, the general investing public will continue to be able to trade the Company's securities.

Key Points: 
  • While the MCTO remains in effect, the general investing public will continue to be able to trade the Company's securities.
  • Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics.
  • This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities legislation (collectively "forward-looking statements").
  • For more information on the Company, its subsidiaries and the risks and challenges of their businesses, investors should review their annual filings that are available at www.sedar.com .

Delic Corp to Present on Company's Expansion Strategy, Industry Outlook at H.C. Wainwright Conference

Retrieved on: 
Wednesday, May 18, 2022

Hosted in the Magic City, the H.C. Wainwright Annual Global Life Sciences Conference is a four-day event consisting of keynote presentations, investor one-on-one meetings, networking opportunities and evening entertainment.

Key Points: 
  • Hosted in the Magic City, the H.C. Wainwright Annual Global Life Sciences Conference is a four-day event consisting of keynote presentations, investor one-on-one meetings, networking opportunities and evening entertainment.
  • At this year's conference, Stang will participate in one-on-one meetings and present the Company's expansion strategy.
  • For those unable to attend this year's conference, his presentation will be available beginning June 10 at 7 a.m. EST.
  • Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics.

DELIC HOLDINGS CORP PROVIDES DEFAULT STATUS UPDATE

Retrieved on: 
Monday, May 16, 2022

VANCOUVER, BC, May 16, 2022 /PRNewswire/ - Delic Holdings Corp ("DELIC" or the "Company") (CSE: DELC ) (OTCQB: DELCF ) (FRA: 6X0 ), a leader in new medicines and treatments for a modern world, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").

Key Points: 
  • VANCOUVER, BC, May 16, 2022 /PRNewswire/ - Delic Holdings Corp ("DELIC" or the "Company") (CSE: DELC ) (OTCQB: DELCF ) (FRA: 6X0 ), a leader in new medicines and treatments for a modern world, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").
  • The Company confirms it will continue to satisfy the provisions of the alternative information guidelines set out in NP 12-203 so long as it remains in default of the requirement to file the Annual Filings.
  • Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics.
  • This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities legislation (collectively "forward-looking statements").

IBN (InvestorBrandNetwork) Announces Success Story Podcast Interview with Delic Holdings Corp Co-Founder and CEO Matt Stang

Retrieved on: 
Thursday, May 5, 2022

The broadcast, hosted by entrepreneur, business executive, author, educator and speaker Scott D. Clary, is available for on-demand viewing on The Success Story Podcast .

Key Points: 
  • The broadcast, hosted by entrepreneur, business executive, author, educator and speaker Scott D. Clary, is available for on-demand viewing on The Success Story Podcast .
  • During the interview, Stang discussed his background in cannabis before explaining his decision to move into psychedelics and co-found Delic.
  • I was an owner and operator of a company called High Times for about 17 years before selling it to a private equity group, Stang said.
  • It began with me writing a senior thesis in college about marijuana legalization in the time of terror, because it was 2001.

Ketamine Wellness Centers (KWC) Introduces NAD+ Infusion Therapy

Retrieved on: 
Wednesday, May 4, 2022

"The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being.

Key Points: 
  • "The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being.
  • For more information about Ketamine Wellness Centers' locations, services and hours of operation, please visit https://www.ketaminewellnesscenters.com/locations /.
  • Ketamine Wellness Centers (KWC) is the largest ketamine therapy provider in the United States with 13 clinic locations serving communities across nine states.
  • Since 2011 KWC has been a trusted leader in bringing IV ketamine therapy into mainstream health care.

Sequire Cannabis & Psychedelic Conference Goes Live on 4/20 With Industry Experts and Investor 1:1s

Retrieved on: 
Thursday, April 7, 2022

This 1-day virtual investor event will be held via SRAXs Sequire Virtual Events platform on April 20th, 2022.

Key Points: 
  • This 1-day virtual investor event will be held via SRAXs Sequire Virtual Events platform on April 20th, 2022.
  • Nearly nine million active small-cap investors have been invited to the event, which will feature over 25 Cannabis & Psychedelic companies hosting 25 minute presentations, alongside keynotes highlighting prominent names in these spaces.
  • The conference is one of many industry specific events that Sequire hosts for their budding investor community.
  • This our second annual Sequire Cannabis & Psychedelic Conference.

IBN (InvestorBrandNetwork) Announces The Jesse Tee Show Interview with Delic Holdings Corp Co-Founder and CEO Matt Stang

Retrieved on: 
Thursday, March 17, 2022

The broadcast, hosted by serial entrepreneur Jesse Todisco, is available for on-demand viewing on The Jesse Tee Show .

Key Points: 
  • The broadcast, hosted by serial entrepreneur Jesse Todisco, is available for on-demand viewing on The Jesse Tee Show .
  • During the interview, Stang discussed his professional background, beginning with an internship at High Times, a leading counterculture publication that became the voice for the cannabis industry.
  • I had a wonderful experience at Burning Man and saw the incredible way that psychedelic culture was going mainstream, Stang explained.
  • These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Matt Stang, CEO of Delic Holdings Corp.

Retrieved on: 
Tuesday, November 16, 2021

The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries.

Key Points: 
  • The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries.
  • Bell2Bells latest podcast features Matt Stang, CEO of Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) , the leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation.
  • The latest installment of The Bell2Bell Podcast continues to reinforce IBNs commitment to the expansion of its robust network of brands, client partners, followers and the growing IBN Podcast Series .
  • These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

Delic Labs Scientific Advisor Professor Glenn Sammis Receives Full Professorship at University of British Columbia

Retrieved on: 
Tuesday, August 10, 2021

VANCOUVER, BC, Aug. 10, 2021 /PRNewswire/ - Delic Corp Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, today announced Professor Glenn Sammis, Scientific Advisor of its subsidiary Delic Labs has been granted a full professorship at the University of British Columbia as a member of the Chemistry Department.

Key Points: 
  • VANCOUVER, BC, Aug. 10, 2021 /PRNewswire/ - Delic Corp Inc. ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, today announced Professor Glenn Sammis, Scientific Advisor of its subsidiary Delic Labs has been granted a full professorship at the University of British Columbia as a member of the Chemistry Department.
  • "It is a great honor to earn a full-time professorship in chemistry with the University of British Columbia," said Delic Labs Scientific Advisor Professor Glenn Sammis.
  • Founded by award-winning chemist, Dr. Markus Roggen, and UBC Professor, Dr. Glenn Sammis, DELIC Labs supports the psychedelic industry with high precision chemical analytics, metabolomic identification and process optimization.
  • Dr. Sammis is now a Full Professor at the Chemistry Department at the University of British Columbia.